[Comment] Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: ... (opens in new tab)

On Feb 4, 2025, The Lancet published an Article by Nirosen Vijiaratnam and colleagues,1 which reported the efficacy and safety of exenatide once weekly as a potential disease-modifying treatment for people with Parkinson's disease in the UK.1 On May 18, 2026, The Lancet was made aware of the findings from a regulatory inspection at King's College Hospital NHS Foundation Trust, one of the clinical trial sites involved in this study, by the corresponding author of the trial. The inspection form...